Overall Status

Completed (1,015)

Terminated (202)

Unknown status (95)

Recruiting (70)

Not yet recruiting (54)

Active, not recruiting (52)

Withdrawn (14)

Enrolling by invitation (5)

Phase

phase 3 (385)

phase 2 (325)

n/a (185)

phase 1 (136)

phase 1/phase 2 (133)

phase 4 (105)

phase 2/phase 3 (24)

early phase 1 (13)

Funder Type

Industry (953)

Other (494)

NIH (53)

U.S. Fed (7)

Study Type

Interventional (1,306)

Observational (181)

Observational [Patient Registry] (20)

Candida

Showing 1 - 25 of 1,507

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Candida Systemic, Candida Albicans Infection, Candida Infection Trial in Santa Monica (CanXida Remove (Formula RMV), Placebo)

Not yet recruiting

Candida Systemic
+2 more

CanXida Remove (Formula RMV)
Placebo

Santa Monica, California

Citruslabs

Nov 19, 2023

Oral Candida Albicans Infection Trial in Alexandria (Probiotic group, Placebo group)

Active, not recruiting

Oral Candida Albicans Infection

Probiotic group
Placebo group

Alexandria, Egypt

Alexandria Faculty of Dentistry

Jan 11, 2023

Plane Wart Trial in Qina (C. albicans antigen, autologous PRP, saline)

Active, not recruiting

Plane Wart

C. albicans antigen
+2 more

Qinā, Egypt

South Valley University

Dec 7, 2022

Squamous Cell Carcinoma of Head and Neck Trial (0.5 mL Candin®/injection, Placebo: 0.5 mL Intravenous 0.9% NaCl solution

Not yet recruiting

Squamous Cell Carcinoma of Head and Neck

0.5 mL Candin®/injection
Placebo: 0.5 mL Intravenous 0.9% NaCl solution (Saline)

(no location specified)

Jul 17, 2023

Candidemia, Invasive Candidiases, Candida Infection Trial in Alberton, Johannesburg (APX001)

Terminated

Has Results

Candidemia
+2 more

APX001

Alberton, Gauteng, South Africa
+1 more

Dec 13, 2022

Warts, Human Papilloma Virus Trial in Zagazig (Candida antigen vaccine, Bivalent HPV vaccine)

Recruiting

Warts
Human Papilloma Virus

Candida antigen vaccine
Bivalent HPV vaccine

Zagazig, Al Sharqia, Egypt

Reham Essam

Jul 26, 2022

Oropharyngeal Candidiasis (OPC) and S-ECC

Recruiting

Candida Infection
+2 more

Philadelphia, Pennsylvania

University of Pennsylvania

Mar 10, 2023

Candida Infection, Premature Infant Trial in Providence (Medium-Chain Triglyceride (MCT) Oil)

Completed

Has Results

Candida Infection
Premature Infant

Medium-Chain Triglyceride (MCT) Oil

Providence, Rhode Island

Women & Infants Hospital of Rhode Island

Mar 10, 2022

Candida Trial in Toulouse (Diagnosis strategy based on C. glabrata / krusei PCR)

Recruiting

Candida

Diagnosis strategy based on C. glabrata / krusei PCR

Toulouse, Occitanie, France

Uh Toulouse

Jul 27, 2022

Hypertriglyceridemia Trial in Cork (Placebo, Candida cylindracea lipase (225,000 FIP lipase units per day), Candida cylindracea

Completed

Hypertriglyceridemia

Placebo
+3 more

Cork, Co. Cork, Ireland

Atlantia Food Clinical Trials, Western Gateway Bldg, University

Mar 21, 2022

Acyclovir and Candida Antigen in Treatment of Plantar Wart Trial in Sohag (Acyclovir 250mg Powder for Solution for Infusion,

Recruiting

Acyclovir and Candida Antigen in Treatment of Plantar Wart

Acyclovir 250mg Powder for Solution for Infusion, each vial contains 250mg of acyclovir as the sodium salt, Chandra Bhagat Pharma Pvt. Ltd andcandida antigen

Sohag, Egypt

Sohag

Jun 17, 2022

Oral Candidiasis, Oral Candidiasis Recurrent, Radiotherapy; Complications Trial in Santiago De Compostela (Vacucis autovaccine,

Not yet recruiting

Oral Candidiasis
+5 more

Vacucis autovaccine
Placebo

Santiago De Compostela, A Coruña, Spain

Universidad de Santiago de Compostela

May 17, 2022

Early Identification of Candida in Intra-abdominal Candidiasis

Recruiting

Candida Sepsis
+3 more

calscreener

Vandoeuvre les Nancy, France

Central Hospital

Feb 22, 2022

Diagnosis and Monitoring of Candidaemia in Hospitalized Patients

Completed

Candida Infection

collection of blood samples

Rome, Roma, Italy

Fondazione PoliclinicoAgostino Gemelli IRCCS

Feb 9, 2023

De-escalation - Antifungal Treatment Immunocompromised Patients

Recruiting

Invasive Fungal Disease
Critical Illness

Lille, France

CHU Lille

Oct 14, 2022

Vulvovaginal Candidiasis, Candida Infection, Vaginal Candidiasis Trial in New Delhi (Non-interventional study)

Recruiting

Vulvovaginal Candidiasis
+2 more

Non-interventional study

New Delhi, Vasant Vihar, India

AWINSA

Jun 8, 2023

Candidiasis, Invasive, Candidemia Trial in Worldwide (SCY-078)

Recruiting

Candidiasis, Invasive
Candidemia

SCY-078

Jersey City, New Jersey
+10 more

Dec 14, 2022

NOBICS - NOvel BIomarker In Invasive CandidiasiS/Candida Sepsis

Completed

Invasive Candidiasis

Graz, Stmk, Austria

Medical University of Graz

Sep 21, 2021

Vaginal Candidiasis, Vulvovaginal Candidiasis, Candidal Vulvovaginitis Trial in Huddinge (VagiVitalAC)

Recruiting

Vaginal Candidiasis
+2 more

VagiVitalAC

Huddinge, Sweden

Karolinska University Hospital

Sep 16, 2021

Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts Trial in Zagazig (Intralesional antigen

Completed

Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts

Intralesional antigen immunotherapy

Zagazig, Sharkia, Egypt

Zagazig university

Feb 14, 2022

Microbiota, Constipation, Candida Trial in Canfield (575mg [30 billion colony forming units] probiotic blend of Bifidobacterium

Completed

Microbiota
+2 more

575mg [30 billion colony forming units] probiotic blend of Bifidobacterium breve, Lactobacillus acidophilus, Lacticaseibacillus rhamnosus, Saccharomyces boulardii, and alpha amylase